Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

OSCA - Olaparib Standard of CAre Study

NCT02262273

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • Research Site Ballarat, Australia
  • Research Site Birtinya, Australia
  • Research Site Campbelltown, Australia
  • Research Site East Melbourne, Australia
View all 199 locations
View Trial Details
Completed

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

NCT02311907

Conditions
Adnexal Diseases, Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, +37 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Northbay Cancer Center Fairfield, California, United States
View all 390 locations
View Trial Details
Completed

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

NCT02262455

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

High-dose ICE With Amifostine

NCT00003657

Conditions
AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +80 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions